Andreas Harsch
VP Preclinical Development at Kymera Therapeutics | Wellesley Hills, Massachusetts, United States
Andreas Harsch’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
VP Preclinical Development at Kymera Therapeutics in November 2022 - Present
Executive Director, Head of DMPK & Toxicology Lead at Frontier Medicines in November 2021 - November 2022
Director at Novartis in June 2014 - October 2021
Associate Director at AstraZeneca in October 2011 - May 2014
Associate Director/Sr. Investigator DMPK at Merck in December 2007 - September 2011
Senior Research Fellow at Merck in August 2004 - November 2007
Senior Scientist II at Abbott Bioresearch Center in March 2001 - August 2004
Senior Scientist I at BASF Bioresearch Center in December 1999 - February 2001
Northeastern University, Post-Doc & Staff Scientist, August 1996 to August 1999
University of Cincinnati, Ph.D., August 1991 to August 1996
University of Stuttgart, Vordiplom, August 1987 to August 1991
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years.
Discover more about Kymera Therapeutics
Associate Director - Clinical Pharmacology at Kymera Therapeutics
Associate Director Clinical Pharmacology at Kymera Therapeutics
(January 2025 – Present)
Translational Medicine and Innovation
Associate Director, Translational Medicine at Kymera Therapeutics
(November 2022 – Present)
Executive Director and Head, Proteomics at Kymera Therapeutics | PhD in Biomedical Research
Executive Director at Kymera Therapeutics
(Jul 2024 – Present)
Executive Director, Process Chemistry, Kymera Therapeutics
Vice President at Kymera Therapeutics
(Feb 2025 – Present)
Director, Site Engagement Leads
Director, Site Engagement Leads at Kymera Therapeutics
(Dec 2025 – Present)
Vice President, Medical Affairs
Vice President Medical Affairs at Kymera Therapeutics
(May 2025 – Present)
What is Andreas Harsch email address?
Email Andreas Harsch at [email protected] and [email protected]. This email is the most updated Andreas Harsch's email found in 2026.
How to contact Andreas Harsch?
To contact Andreas Harsch send an email to [email protected] or [email protected]. (updated on October 04, 2025)
What company does Andreas Harsch work for?
Andreas Harsch works for Kymera Therapeutics.
What is Andreas Harsch's role at Kymera Therapeutics?
Andreas Harsch is VP Preclinical Development
What industry does Andreas Harsch work in?
Andreas Harsch works in the Pharmaceuticals industry.
